These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21611115)

  • 1. Platinum agent-induced hypersensitivity reactions: data mining of the public version of the FDA adverse event reporting system, AERS.
    Sakaeda T; Kadoyama K; Yabuuchi H; Niijima S; Seki K; Shiraishi Y; Okuno Y
    Int J Med Sci; 2011; 8(4):332-8. PubMed ID: 21611115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse event profiles of platinum agents: data mining of the public version of the FDA adverse event reporting system, AERS, and reproducibility of clinical observations.
    Sakaeda T; Kadoyama K; Okuno Y
    Int J Med Sci; 2011; 8(6):487-91. PubMed ID: 21897761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS.
    Kadoyama K; Kuwahara A; Yamamori M; Brown JB; Sakaeda T; Okuno Y
    J Exp Clin Cancer Res; 2011 Oct; 30(1):93. PubMed ID: 21970649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin-associated muscular and renal adverse events: data mining of the public version of the FDA adverse event reporting system.
    Sakaeda T; Kadoyama K; Okuno Y
    PLoS One; 2011; 6(12):e28124. PubMed ID: 22205938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse event profiles of 5-fluorouracil and capecitabine: data mining of the public version of the FDA Adverse Event Reporting System, AERS, and reproducibility of clinical observations.
    Kadoyama K; Miki I; Tamura T; Brown JB; Sakaeda T; Okuno Y
    Int J Med Sci; 2012; 9(1):33-9. PubMed ID: 22211087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin- and clopidogrel-associated bleeding complications: data mining of the public version of the FDA adverse event reporting system, AERS.
    Tamura T; Sakaeda T; Kadoyama K; Okuno Y
    Int J Med Sci; 2012; 9(6):441-6. PubMed ID: 22859904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential use of data-mining algorithms for the detection of 'surprise' adverse drug reactions.
    Hauben M; Horn S; Reich L
    Drug Saf; 2007; 30(2):143-55. PubMed ID: 17253879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity and idiosyncratic reactions to oxaliplatin.
    Thomas RR; Quinn MG; Schuler B; Grem JL
    Cancer; 2003 May; 97(9):2301-7. PubMed ID: 12712487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal detection in FDA AERS database using Dirichlet process.
    Hu N; Huang L; Tiwari RC
    Stat Med; 2015 Aug; 34(19):2725-42. PubMed ID: 25924820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse event profile of tigecycline: data mining of the public version of the U.S. Food and Drug Administration adverse event reporting system.
    Kadoyama K; Sakaeda T; Tamon A; Okuno Y
    Biol Pharm Bull; 2012; 35(6):967-70. PubMed ID: 22687540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin-associated hypersensitivity reactions: clinical presentation and management.
    Hewitt MR; Sun W
    Clin Colorectal Cancer; 2006 Jul; 6(2):114-7. PubMed ID: 16945166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing taxane-associated adverse events using the FDA adverse event reporting system database.
    Lao DH; Chen Y; Fan J; Zhang JZ
    Chin Med J (Engl); 2021 Jun; 134(12):1471-1476. PubMed ID: 34074841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
    DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
    Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicities of the platinum antineoplastic agents.
    Markman M
    Expert Opin Drug Saf; 2003 Nov; 2(6):597-607. PubMed ID: 14585068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AERS spider: an online interactive tool to mine statistical associations in Adverse Event Reporting System.
    Grigoriev I; zu Castell W; Tsvetkov P; Antonov AV
    Pharmacoepidemiol Drug Saf; 2014 Aug; 23(8):795-801. PubMed ID: 24677538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin hypersensitivity reactions: re-treatment with cisplatin desensitisation.
    Jones R; Ryan M; Friedlander M
    Gynecol Oncol; 2003 Apr; 89(1):112-5. PubMed ID: 12694663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin salvage for recurrent ovarian cancer: a single institution's experience in patient populations with platinum resistant disease or a history of platinum hypersensitivity.
    Taylor SE; Beck TL; Krivak TC; Zorn KK; Kelley JL; Edwards RP
    Gynecol Oncol; 2014 Jul; 134(1):68-72. PubMed ID: 24769036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxin-like reactions with intravenous gentamicin: results from pharmacovigilance tools under investigation.
    Hauben M; Reich L
    Infect Control Hosp Epidemiol; 2005 Apr; 26(4):391-4. PubMed ID: 15865275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omeprazole- and esomeprazole-associated hypomagnesaemia: data mining of the public version of the FDA Adverse Event Reporting System.
    Tamura T; Sakaeda T; Kadoyama K; Okuno Y
    Int J Med Sci; 2012; 9(5):322-6. PubMed ID: 22745572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A real-world pharmacovigilance study of axitinib: data mining of the public version of FDA adverse event reporting system.
    Shu Y; Ding Y; Dai B; Zhang Q
    Expert Opin Drug Saf; 2022 Apr; 21(4):563-572. PubMed ID: 34918584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.